ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
133.337,91
0,25%
S&P 500
5.750,36
0,09%
US Dollar vs BRL
5,4358
-0,04%
Bitcoin
66.158,00
1,50%
Brent Oil
71,755
1,13%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. ETFs
  4. EUA
  5. NASDAQ
  6. KraneShares Artificial Intelligence ETF (AGIX)

  7. KraneShares Artificial Intelligence ETF (AGIX) Notícias

AGIX

KraneShares Artificial I... (AGIX)

KraneShares Artificial Intelligence ETF
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:AGIX
DataHoraFonteTítuloCódigoCompanhia
10/10/200818:23Edgar (US Regulatory)Current report filing (8-K)NASDAQ:AGIXKraneShares Artificial Intelligence ETF
10/10/200818:15MarketwiredAtheroGenics Receives Delisting Notice From NASDAQ Global Market Due to Chapter 11 FilingNASDAQ:AGIXKraneShares Artificial Intelligence ETF
10/10/200816:35Edgar (US Regulatory)Withdrawal of Registration Statement (RW)NASDAQ:AGIXKraneShares Artificial Intelligence ETF
07/10/200809:20Edgar (US Regulatory)Atherogenics Inc - Current report filing (8-K)NASDAQ:AGIXKraneShares Artificial Intelligence ETF
07/10/200807:51MarketwiredAtheroGenics Files for Chapter 11 BankruptcyNASDAQ:AGIXKraneShares Artificial Intelligence ETF
10/09/200820:13MarketwiredAtheroGenics Restructures Board of DirectorsNASDAQ:AGIXKraneShares Artificial Intelligence ETF
02/09/200812:44MarketwiredBellwetherReport.com Analyst Opinions on SCRX, AGIX, BUCY and ISILNASDAQ:AGIXKraneShares Artificial Intelligence ETF
02/09/200809:39MarketwiredAtheroGenics Seeks to Realign Capital StructureNASDAQ:AGIXKraneShares Artificial Intelligence ETF
25/08/200816:00Edgar (US Regulatory)Atherogenics Inc - Confidential Treatment Order (CT ORDER)NASDAQ:AGIXKraneShares Artificial Intelligence ETF
20/08/200807:24Edgar (US Regulatory)Atherogenics Inc - Application for qualification of trust indentures (T-3)NASDAQ:AGIXKraneShares Artificial Intelligence ETF
05/08/200808:00MarketwiredAtheroGenics Reports Second Quarter 2008 Financial ResultsNASDAQ:AGIXKraneShares Artificial Intelligence ETF
01/08/200811:20PR Newswire (US)BeaconEquity.com Issues Technical Trade Alerts on Market Movers: AGIX, APKT, BIOS, NOVA, CNXT, CHRDNASDAQ:AGIXKraneShares Artificial Intelligence ETF
31/07/200812:27MarketwiredBellwetherReport.com Analyst Report on HOLX, AKAM, SBUX and AGIXNASDAQ:AGIXKraneShares Artificial Intelligence ETF
31/07/200808:00MarketwiredAtheroGenics Reports Positive Results From ANDES Phase 3 Clinical Trial of AGI-1067 in Type 2 DiabetesNASDAQ:AGIXKraneShares Artificial Intelligence ETF
25/07/200808:15MarketwiredAtheroGenics to Report Second Quarter 2008 Financial Results on August 5, 2008NASDAQ:AGIXKraneShares Artificial Intelligence ETF
30/06/200810:21MarketwiredAtheroGenics Receives Notice of Non-Compliance With Listing Requirement for the NASDAQ Global MarketNASDAQ:AGIXKraneShares Artificial Intelligence ETF
19/06/200810:20PR Newswire (US)BeaconEquity.com Issues TraderNotes on Stocks: TPIM, NSM, BRLC, AGIX, AROX, TLEO, HLYS, ABATNASDAQ:AGIXKraneShares Artificial Intelligence ETF
10/06/200810:17MarketwiredAtheroGenics Reports Clinical Data on Novel Anti-Inflammatory Anti-Oxidant Agent, AGI-1067, at American Diabetes Association AnnNASDAQ:AGIXKraneShares Artificial Intelligence ETF
04/06/200808:30MarketwiredAtheroGenics Announces Five Abstracts Accepted for the American Diabetes Association's 68th Annual Scientific SessionsNASDAQ:AGIXKraneShares Artificial Intelligence ETF
23/05/200816:38Edgar (US Regulatory)Atherogenics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AGIXKraneShares Artificial Intelligence ETF
22/05/200821:55MarketwiredAtheroGenics' ARISE Trial Results Published in The LancetNASDAQ:AGIXKraneShares Artificial Intelligence ETF
09/05/200818:10Edgar (US Regulatory)Atherogenics Inc - Quarterly Report (10-Q)NASDAQ:AGIXKraneShares Artificial Intelligence ETF
30/04/200815:51Marketwired/ CORRECTION - AtheroGenics to Present at the 2008 Morgan Stanley Global Healthcare Unplugged Conference on May 2, 2008NASDAQ:AGIXKraneShares Artificial Intelligence ETF
30/04/200811:57MarketwiredAtheroGenics to Present at the 2008 Morgan Stanley Global Healthcare Unplugged Conference on May 2, 2008NASDAQ:AGIXKraneShares Artificial Intelligence ETF
24/04/200808:00MarketwiredAtheroGenics Reports First Quarter 2008 Financial ResultsNASDAQ:AGIXKraneShares Artificial Intelligence ETF
18/04/200810:33Edgar (US Regulatory)Atherogenics Inc - Proxy Statement (definitive) (DEF 14A)NASDAQ:AGIXKraneShares Artificial Intelligence ETF
17/04/200810:18MarketwiredAtheroGenics to Report First Quarter 2008 Financial Results on April 24, 2008NASDAQ:AGIXKraneShares Artificial Intelligence ETF
14/04/200808:00MarketwiredAtheroGenics Announces Encouraging Interim Results From Phase 3 Clinical Trial of AGI-1067 in Type 2 DiabetesNASDAQ:AGIXKraneShares Artificial Intelligence ETF
07/04/200817:38Edgar (US Regulatory)Atherogenics Inc - Amended Statement of Changes in Beneficial Ownership (4/A)NASDAQ:AGIXKraneShares Artificial Intelligence ETF
11/03/200810:31MarketwiredAtheroGenics to Present at Lehman Brothers Global Healthcare Conference March 18, 2008NASDAQ:AGIXKraneShares Artificial Intelligence ETF
 Apresentando as notícias mais relevantes sobre:NASDAQ:AGIX

Seu Histórico Recente

LSE
FU32
Bridgegate.62 A
LSE
FC37
Qnb Fin 25
NASDAQ
DSGX
Descartes Systems
TSXV
ADZN
Adventus Mining
NASDAQ
PSL
Invesco Trust Invesco Do...
LSE
65SL
Nibc.4.51%
LSE
IEX5
BlackRock Asset Manageme...
COIN
NXBUSD
NASDAQI
CRSPLCG1
CRSP US Large Cap Growth
COIN
MGXETH
MEGA X
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados